2018 International Congress

Saturday, October 6, 2018

1:45pm-3:15pm

Bilateral stereotypy after unilateral cerebellar infarction

S. Choi, C. Shin, T. Ahn (Seoul, Republic of Korea)

Tics/Stereotypies  ·  Hall 3FG

1:45pm-3:15pm

Bilateral subthalamic deep brain stimulation combined with thalamotomy for PRRT2-associated generalized dystonia: A case report

DD. Zhang, JL. Liu, J. Yan, XJ. She, XD. Cai (Shenzhen, China)

Surgical Therapy: Other Movement Disorders  ·  Hall 3FG

1:45pm-3:15pm

Bio-Electro Stimulation Therapy for the Treatment of Motor and Non-Motor Symptoms in Parkinson’s Disease

T. Tsao, C. Fontana, A. Waite (Boston, MA, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG

1:45pm-3:15pm

Biofabricated tissue constructs to recapitulate the anatomy and functionality of the nigrostriatal pathway in Parkinson’s disease

J. Duda, L. Struzyna, K. Browne, H. Chen, D. Cullen (Philadelphia, PA, USA)

Therapy in Movement Disorders: Gene and Cell-Based Therapies  ·  Hall 3FG

1:45pm-3:15pm

Biological course and natural history of hereditary spastic paraplegia type 11 (SPG11)

T. Musacchio, K. Nohl, K. Boelmans, V. Maltese, D. Zeller, I. Isaias, J. Volkmann, S. Klebe (Würzburg, Germany)

Rare Genetic and Metabolic Diseases  ·  Hall 3FG

1:45pm-3:15pm

Bipolar directional DBS in VIM-stimulated patients

J. Steffen, P. Reker, F. Mennicken, T. Dembek, H. Dafsari, G. Fink, V. Visser-Vandewalle, M. Barbe (Cologne, Germany)

Clinical Trials and Therapy in Movement Disorders  ·  Hall 3FG

1:45pm-3:15pm

Blinded acute assessment of electrode contact efficacy compared with contact location for Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease

G. Lim, B. Jonker, S. Bolitho, S. Tisch (Sydney, Australia)

Surgical Therapy: Parkinson's Disease  ·  Hall 3FG

1:45pm-3:15pm

Botulinum toxin in Essential Hand Tremor – A Randomized Double-Blind Placebo-Controlled study with Customized Injection Approach

S. Mittal, D. Machado, D. Richardson, D. Dubey, B. Jabbari (Bangalore, India)

Clinical Trials and Therapy in Movement Disorders  ·  Hall 3FG

1:45pm-3:15pm

Botulinum toxin injection for Pisa syndrome in Parkinson’s disease

CA. Artusi, M. Zibetti, P. Barbero, M. Busso, S. Bortolani, S. De Mercanti, P. Arnoffi, M. Fabbri, A. Merola, L. Lopiano (Torino, Italy)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG

1:45pm-3:15pm

Brief Cognitive Screening for Parkinson’s disease by the Korean Version of the Montreal Cognitive Assessment

M. Park, D. Kwon (Ansan-city, Korea)

Cognitive Disorders  ·  Hall 3FG